European Association for the Study of Diabetes (EASD) 57th Annual Meeting
Oct 01, 2021 at 12:00 PM CEST
The abstract entitled, "AG019 ActoBiotics as monotherapy or in association with teplizumab in recent-onset type 1 diabetes was safe and demonstrated encouraging metabolic and immunological effects" was presented by Chantal Mathieu, MD, PhD, Professor of Medicine at the Katholieke Universiteit Leuven, Belgium.
Supporting Materials
View presentation 7.4 MB